ComingTechs was born from a shared frustration. Our founders—a team of regulatory experts, biotech executives, and AI specialists—had experienced firsthand the inefficiencies and bottlenecks that plague the healthcare innovation journey. They saw promising technologies delayed or abandoned not because of scientific limitations, but because of regulatory complexity, resource constraints, and strategic missteps.
In 2016, they came together with a bold vision: to create a new kind of consultancy that would leverage artificial intelligence to transform how biotech and healthcare innovations navigate the path to market. They believed that by combining deep domain expertise with cutting-edge AI capabilities, they could dramatically accelerate the development and approval process while reducing costs and improving outcomes.
The early days were spent developing proprietary AI platforms designed specifically for healthcare regulatory and strategic challenges. The team analyzed thousands of regulatory submissions, clinical trials, and commercialization journeys to identify patterns, success factors, and optimization opportunities that human analysis alone might miss.
By 2022, ComingTechs launched its first AI-powered services, helping a small group of pilot clients navigate regulatory submissions with unprecedented speed and accuracy. Word spread quickly as these early clients achieved remarkable results—regulatory approvals in half the expected time, successful funding rounds, and efficient market entries.
Today, ComingTechs has grown into a trusted partner for biotech and healthcare innovators across the globe, from early-stage startups to established enterprises. While our team and capabilities have expanded, our mission remains the same: to accelerate healthcare innovation by removing the barriers between groundbreaking science and the patients who need it.